Abstract
Conventionally, cancer is treated as a homogenous mass of highly proliferative cells, with therapeutics designed to destroy rapidly dividing cells. However, not only are cancers heterogeneous, but also small subsets are endowed with the ability to initiate cancer formation and metastasis. The resistance of cancer initiating cells to current therapies may explain high relapse rates. Our inability to eradicate cancer may be due to misrecognition of the proper cancer target. Designing novel therapeutics for cancer eradication will require understanding specific pathways involved in cancer initiating cell self-renewal, differentiation and homing. Furthermore, targeting the distinctions of the cancer initiating cell microenvironment may be key to effective cancer therapies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aicher, A. and C. Heeschen (2007). “Nonbone marrow-derived endothelial progenitor cells: What is their exact location?” Circ Res 101(9): e102.
Al-Hajj, M., M. S. Wicha, et al. (2003). “Prospective identification of tumorigenic breast cancer cells.” Proc Natl Acad Sci USA 100(7): 3983–8.
Avital, I., A. L. Moreira, et al. (2007). “Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation.” Stem Cells 25(11): 2903–9.
Bailey, J. M., P. K. Singh, et al. (2007). “Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins.” J Cell Biochem 102(4): 829–39.
Bao, S., Q. Wu, et al. (2006a). “Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.” Nature 444(7120): 756–60.
Bao, S., Q. Wu, et al. (2006b). “Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.” Cancer Res 66(16): 7843–8.
Bolontrade, M. F., R. R. Zhou, et al. (2002). “Vasculogenesis Plays a Role in the Growth of Ewing’s Sarcoma in Vivo.” Clin Cancer Res 8(11): 3622–7.
Bonnet, D. and J. E. Dick (1997). “Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.” Nat Med 3(7): 730–7.
Braakhuis, B. J., M. P. Tabor, et al. (2003). “A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications.” Cancer Res 63(8): 1727–30.
Brinster, R. (1874). “The effect of cells transferred into the mouse blastocyst on subsequent development.” J Exp Med 140: 1049–1056.
Buzzeo, M. P., E. W. Scott, et al. (2007). “The hunt for cancer-initiating cells: a history stemming from leukemia.” Leukemia 21(8): 1619–27.
Calabrese, C., H. Poppleton, et al. (2007). “A perivascular niche for brain tumor stem cells.” Cancer Cell 11(1): 69–82.
Calvi, L. M., G. B. Adams, et al. (2003). “Osteoblastic cells regulate the haematopoietic stem cell niche.” Nature 425(6960): 841–6.
Case, J., L. E. Mead, et al. (2007). “Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.” Exp Hematol 35(7): 1109–18.
Chauncey, T. R., C. Rankin, et al. (2000). “A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.” Leuk Res 24(7): 567–74.
Clarke, M. F., J. E. Dick, et al. (2006). “Cancer stem cells – perspectives on current status and future directions: AACR Workshop on cancer stem cells.” Cancer Res 66(19): 9339–44.
Clevers, H. (2006). “Wnt/beta-catenin signaling in development and disease.” Cell 127(3): 469–80.
Cobaleda, C., N. Gutierrez-Cianca, et al. (2000). “A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.” Blood 95(3): 1007–13.
Cogle, C. R., N. D. Theise, et al. (2007). “Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry.” Stem Cells 25(8): 1881–7.
Cohnheim, J. (1867). “Ueber entzundung und eiterung.” Path Anat Physiol Klin Med 40: 1–79.
Collins, A. T., P. A. Berry, et al. (2005). “Prospective identification of tumorigenic prostate cancer stem cells.” Cancer Res 65(23): 10946–51.
Cucina, A., P. M. Biava, et al. (2006). “Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2).” Apoptosis 11(9): 1617–28.
Dalerba, P., S. J. Dylla, et al. (2007). “Phenotypic characterization of human colorectal cancer stem cells.” Proc Natl Acad Sci USA 104(24): 10158–63.
De Palma, M., M. A. Venneri, et al. (2003). “Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.” Nat Med 9(6): 789–95.
Donnenberg, V. S. and A. D. Donnenberg (2005). “Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.” J Clin Pharmacol 45(8): 872–7.
Duda, D. G., K. S. Cohen, et al. (2006). “Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.” Blood 107(7): 2774–6.
Durante, F. (1874). “Nesso fisiopathologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni.” Arch Memori ed Osservazioni di Chirugia Practica 11: 217–226.
Dwenger, A., F. Rosenthal, et al. (2004). “Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs.” Stem Cells 22(1): 86–92.
Fang, D., T. K. Nguyen, et al. (2005). “A tumorigenic subpopulation with stem cell properties in melanomas.” Cancer Res 65(20): 9328–37.
Fialkow, P. J., R. J. Jacobson, et al. (1977). “Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.” Am J Med 63(1): 125–30.
Friedewald, W. and P. Rous (1944). “The initiating and promiting elements in tumor production: an analysis of the effects of tar, benzpyrene, and methylcholanthrene on rabbit skin.” Journal of Experimental Medicine 80: 101–126.
Fujino, H., H. Hiramatsu, et al. (2007). “Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/gamma(c)null mice through cell fusion.” Faseb J 21(13): 3499–510.
Furth, J. and M. Kahn (1937). “The transmission of leukemia of mice with a single cell.” Am J Cancer(31): 276–282.
Gao, D., D. J. Nolan, et al. (2008). “Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis.” Science 319(5860): 195–8.
Gat, U., R. DasGupta, et al. (1998). “De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.” Cell 95(5): 605–14.
Gerschenson, M., K. Graves, et al. (1986). “Regulation of melanoma by the embryonic skin.” Proc Natl Acad Sci USA 83(19): 7307–10.
Gibbs, C. P., V. G. Kukekov, et al. (2005). “Stem-like cells in bone sarcomas: implications for tumorigenesis.” Neoplasia 7(11): 967–76.
Goodell, M. A. (2003). “Stem-cell “plasticity”: befuddled by the muddle.” Curr Opin Hematol 10(3): 208–13.
Gootwine, E., C. G. Webb, et al. (1982). “Participation of myeloid leukaemic cells injected into embryos in haematopoietic differentiation in adult mice.” Nature 299(5878): 63–5.
Gothert, J. R., S. E. Gustin, et al. (2004). “Genetically tagging endothelial cells in vivo:bone marrow-derived cells do not contribute to tumor endothelium.” Blood 2004 Sep 15; 104(6): 1769–77. Epub 2004 Jun 8.
Gunsilius, E., H. C. Duba, et al. (2000). “Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.” Lancet 355(9216): 1688–91.
Hammerling, G. J. and R. Ganss (2006). “Vascular integration of endothelial progenitors during multistep tumor progression.” Cell Cycle 5(5): 509–11.
Haramis, A. P., H. Begthel, et al. (2004). “De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine.” Science 303(5664): 1684–6.
He, T. C., T. A. Chan, et al. (1999). “PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.” Cell 99(3): 335–45.
He, T. C., A. B. Sparks, et al. (1998). “Identification of c-MYC as a target of the APC pathway.” Science 281(5382): 1509–12.
He, X. C., J. Zhang, et al. (2004). “BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling.” Nat Genet 36(10): 1117–21.
Herzog, E. L., L. Chai, et al. (2003). “Plasticity of marrow-derived stem cells.” Blood 102(10): 3483–93.
Houghton, J., C. Stoicov, et al. (2004). “Gastric cancer originating from bone marrow-derived cells.” Science 306(5701): 1568–71.
Hurwitz, H., L. Fehrenbacher, et al. (2004). “Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.” N Engl J Med 350(23): 2335–42.
Ignatova, T. N., V. G. Kukekov, et al. (2002). “Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.” Glia 39(3): 193–206.
Ikoma, N., H. Yamazaki, et al. (2005). “S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.” Oncol Rep 14(3): 633–7.
Ito, M., H. Hiramatsu, et al. (2002). “NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.” Blood 100(9): 3175–82.
Jaiswal, S., D. Traver, et al. (2003). “Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.” Proc Natl Acad Sci USA 100(17): 10002–7.
Jamieson, C. H., L. E. Ailles, et al. (2004). “Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.” N Engl J Med 351(7): 657–67.
Jiang, X., Y. Zhao, et al. (2007). “Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.” Leukemia 2007 May; 21(5): 926–35. Epub 2007 Mar 1.
Jin, L., K. J. Hope, et al. (2006). “Targeting of CD44 eradicates human acute myeloid leukemic stem cells.” Nat Med 12(10): 1167–74.
Kaplan, R. N., R. D. Riba, et al. (2005). “VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.” Nature 438(7069): 820–7.
Katayama, Y., M. Battista, et al. (2006). “Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.” Cell 124(2): 407–21.
Kiel, M. J., O. H. Yilmaz, et al. (2005). “SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.” Cell 121(7): 1109–21.
Kim, C. F., E. L. Jackson, et al. (2005). “Identification of bronchioalveolar stem cells in normal lung and lung cancer.” Cell 121(6): 823–35.
Kinzler, K. W., M. C. Nilbert, et al. (1991). “Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers.” Science 251(4999): 1366–70.
Krause, D. S., K. Lazarides, et al. (2006). “Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.” Nat Med 12(10): 1175–80.
Lantos, P. L. and D. J. Cox (1976). “The origin of experimental brain tumours: a sequential study.” Experientia 32(11): 1467–8.
Lapidot, T., C. Sirard, et al. (1994). “A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.” Nature 367(6464): 645–8.
Larrivee, B., K. Niessen, et al. (2005). “Minimal contribution of marrow-derived endothelial precursors to tumor vasculature.” J Immunol 175(5): 2890–9.
Lee, T. H., M. F. Bolontrade, et al. (2006). “Production of VEGF165 by Ewing’s sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.” Int J Cancer 119(4): 839–46.
Leith, C. P., K. J. Kopecky, et al. (1999). “Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.” Blood 94(3): 1086–99.
Li, C., D. G. Heidt, et al. (2007). “Identification of pancreatic cancer stem cells.” Cancer Res 67(3): 1030–7.
Li, L. and W. B. Neaves (2006). “Normal stem cells and cancer stem cells: the niche matters.” Cancer Res 66(9): 4553–7.
Lord, B. I., N. G. Testa, et al. (1975). “The relative spatial distributions of CFUs and CFUc in the normal mouse femur.” Blood 46(1): 65–72.
Lyden, D., K. Hattori, et al. (2001). “Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.” Nat Med 7(11): 1194–201.
Martin, G. R. (1980). “Teratocarcinomas and mammalian embryogenesis.” Science 209(4458): 768–76.
Matsui, W., C. A. Huff, et al. (2004). “Characterization of clonogenic multiple myeloma cells.” Blood 103(6): 2332–6.
Mintz, B. and K. Illmensee (1975). “Normal genetically mosaic mice produced from malignant teratocarcinoma cells.” Proc Natl Acad Sci USA 72(9): 3585–9.
Muller, A., B. Homey, et al. (2001). “Involvement of chemokine receptors in breast cancer metastasis.” Nature 410(6824): 50–6.
Nolan, D. J., A. Ciarrocchi, et al. (2007). “Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.” Genes Dev 21(12): 1546–58.
Nuciforo, P. and F. Fraggetta (2004). “Cancer stem cell theory: pathologists’ considerations and ruminations about wasting time and wrong evaluations.” J Clin Pathol 57(7): 782.
O’Brien, C. A., A. Pollett, et al. (2007). “A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.” Nature 445(7123): 106–10.
Palmer, T. D., A. R. Willhoite, et al. (2000). “Vascular niche for adult hippocampal neurogenesis.” J Comp Neurol 425(4): 479–94.
Papaioannou, V. E., M. W. McBurney, et al. (1975). “Fate of teratocarcinoma cells injected into early mouse embryos.” Nature 258(5530): 70–73.
Patrawala, L., T. Calhoun, et al. (2006). “Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.” Oncogene 25(12): 1696–708.
Perez-Losada, J. and A. Balmain (2003). “Stem-cell hierarchy in skin cancer.” Nat Rev Cancer 3(6): 434–43.
Peters, B. A., L. A. Diaz, et al. (2005). “Contribution of bone marrow-derived endothelial cells to human tumor vasculature.” Nat Med 11(3): 261–2.
Piccirillo, S. G., B. A. Reynolds, et al. (2006). “Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.” Nature 444(7120): 761–5.
Podesta, A. H., J. Mullins, et al. (1984). “The neurula stage mouse embryo in control of neuroblastoma.” Proc Natl Acad Sci USA 81(23): 7608–11.
Prince, M. E., R. Sivanandan, et al. (2007). “Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.” Proc Natl Acad Sci USA 104(3): 973–8.
Ratajczak, M. Z., E. Zuba-Surma, et al. (2006). “The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.” Leukemia 20(11): 1915–24.
Ricci-Vitiani, L., D. G. Lombardi, et al. (2007). “Identification and expansion of human colon-cancer-initiating cells.” Nature 445(7123): 111–5.
Rigolin, G. M., C. Fraulini, et al. (2006). “Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion.” Blood 107(6): 2531–5.
Rigolin, G. M., E. Mauro, et al. (2007). “Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia.” Eur J Haematol 78(5): 365–73.
Rotter, W. (1921). “Histogenese der malignen Geschwulste.” Ztschr Krebsforschung 18: 171–208.
Sanai, N., A. Alvarez-Buylla, et al. (2005). “Neural stem cells and the origin of gliomas.” N Engl J Med 353(8): 811–22.
Santarelli, J. G., V. Udani, et al. (2006). “Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain.” Neurosurgery 59(2): 374–82; discussion 374–82.
Scadden, D. T. (2006). “The stem-cell niche as an entity of action.” Nature 441(7097): 1075–9.
Shinde Patil, V. R., E. B. Friedrich, et al. (2005). “Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.” Neoplasia 7(3): 234–40.
Singh, S. K., C. Hawkins, et al. (2004). “Identification of human brain tumour initiating cells.” Nature 432(7015): 396–401.
Sirard, C., T. Lapidot, et al. (1996). “Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.” Blood 87(4): 1539–48.
Slaughter, D. P., H. W. Southwick, et al. (1953). “Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.” Cancer 6(5): 963–8.
Streubel, B., A. Chott, et al. (2004). “Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas.” N Engl J Med 351(3): 250–9.
Taichman, R. S. (2005). “Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche.” Blood 105(7): 2631–9.
Tsukamoto, A. S., R. Grosschedl, et al. (1988). “Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.” Cell 55(4): 619–25.
Udani, V. M., J. G. Santarelli, et al. (2005). “Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis.” Stem Cells Dev 14(5): 478–86.
Vick, N. A., M. J. Lin, et al. (1977). “The role of the subependymal plate in glial tumorigenesis.” Acta Neuropathol 40(1): 63–71.
Virchow, R. (1855). “Editoral Archiv fuer pathologische.” Anatomie und Physiologie und fuer klinische Medizin 8: 23.
Zentilin, L., S. Tafuro, et al. (2006). “Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels.” Blood 107(9): 3546–54.
Zhang, J., C. Niu, et al. (2003). “Identification of the haematopoietic stem cell niche and control of the niche size.” Nature 425(6960): 836–41.
Zhang, T., T. Otevrel, et al. (2001). “Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.” Cancer Res 61(24): 8664–7.
Zhao, C., J. Blum, et al. (2007). “Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.” Cancer Cell 12(6): 528–41.
Ziegelhoeffer, T., B. Fernandez, et al. (2004). “Bone marrow-derived cells do not incorporate into the adult growing vasculature.” Circ Res 94(2): 230–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Cogle, C.R. (2009). Cancer, Stem Cells and the Neoplastic Niche. In: Baronzio, G., Fiorentini, G., Cogle, C.R. (eds) Cancer Microenvironment and Therapeutic Implications. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9576-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9576-4_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9575-7
Online ISBN: 978-1-4020-9576-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)